CERo Therapeutics Holdings, Inc.
CERO · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $14,495 | $161,766 | $151,031 | $145,736 |
| - Cash | $3,327 | $1,601 | $42,142 | $1,099 |
| + Debt | $1,575 | $1,555 | $650 | $3,602 |
| Enterprise Value | $12,744 | $161,720 | $109,539 | $148,240 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1,163 | -$1,117 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6,569 | -$2,438 | -$69 | $403 |
| % Margin | – | – | – | – |
| Net Income | -$7,732 | -$3 | -$668 | -$316 |
| % Margin | – | – | – | – |
| EPS Diluted | -6.87 | -2,497.2 | -19.73 | -2.75 |
| % Growth | 99.7% | -12,556.9% | -617.5% | – |
| Operating Cash Flow | -$5,790 | -$5,790 | -$1,092 | -$697 |
| Capital Expenditures | $0 | -$0 | -$694 | -$613 |
| Free Cash Flow | -$5,790 | -$5,790 | -$1,786 | -$1,310 |